Stock data
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA) reported net income of -US$90.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$93.33M | -US$90.60M | — |
| 2024 | — | — | -US$115.95M | -US$111.13M | — |
| 2023 | — | — | -US$131.19M | -US$124.08M | — |
| 2022 | — | — | -US$125.62M | -US$123.67M | — |
| 2021 | — | — | -US$72.81M | -US$72.72M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.11M | -US$43.39M | — |
| 2026-03-31 | US$0.23M | -US$19.27M | — |
| 2025-12-31 | — | -US$20.18M | — |
| 2025-09-30 | — | -US$20.27M | — |
| 2025-06-30 | US$0.00M | -US$23.28M | — |
| 2025-03-31 | US$0.00M | -US$26.86M | — |
| 2024-12-31 | — | -US$23.84M | — |
| 2024-09-30 | — | -US$25.63M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.